Intellia reports positive data from Phase II study of NTLA-2002 for HAE
Intellia Therapeutics has reported positive results from its ongoing Phase I/II trial of NTLA-2002, a CRISPR-based gene editing therapy for …
Intellia Therapeutics has reported positive results from its ongoing Phase I/II trial of NTLA-2002, a CRISPR-based gene editing therapy for …
A lack of diversity among participants in clinical trials can exacerbate existing health disparities by limiting how applicable research findings …
Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit from early advanced therapy …
Marinus Pharmaceuticals has reported that the Phase III TrustTSC trial of oral ganaxolone in treating seizures linked to tuberous sclerosis …
GeneDx has unveiled new findings from the GUARDIAN study, a large research effort to assess the effectiveness of whole genome …
On 23 October 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s anti-amyloid beta (Aβ) monoclonal antibody …
ImmunityBio has announced the commencement of a Phase I clinical trial evaluating its CD19 targeted high-affinity natural killer (t-haNK) cell …
The pharmaceutical industry is undergoing significant changes, with clinical trials becoming increasingly complex and extending beyond traditional geographical boundaries. Novotech, …
Pharmaceutical supply chains are some of the world’s most intricate. Recent developments have only heightened the challenges for companies on …
Onward Medical has raised $54m (€50m) via a bookbuild offering, with proceeds going towards ongoing clinical studies and an expected …
OKYO Pharma has initiated the Phase II trial of OK-101, a treatment for neuropathic corneal pain (NCP), by dosing the …
During IDWeek 2024 in Los Angeles, California, US, case studies highlighted the current methods for detecting and preventing nontuberculous mycobacteria …
Managing chronic myeloid leukemia (CML) can be challenging, especially when it comes to accurately tracking how well patients respond to …
AngioDynamics has teamed up with the University College London Hospital (UCLH) in the UK to launch a prospective registry study …
US-based device company Luna Diabetes has initiated a pivotal trial evaluating its automated closed-loop insulin technology, the Luna System, in …